1. The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
   Huanbiao Mo et al, 2019, Front. Pharmacol. CrossRef
2. Lamin A and Prelamin a Counteract Migration of Osteosarcoma Cells
   Camilla Evangelisti et al, 2020, Cells CrossRef
3. The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
   Heinrich Kovar et al, 2020, Cells CrossRef
4. Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective
   Anita K. Luu et al, 2020, IJMS CrossRef
5. The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
   Borja Guerra et al, 2021, Front. Oncol. CrossRef
6. Porous Composite Granules with Potential Function of Bone Substitute and Simvastatin Releasing System: A Preliminary Study
   Aleksandra Laskus-Zakrzewska et al, 2021, Materials CrossRef
7. Alleviation of Simvastatin-Induced Myopathy in Rats by the Standardized Extract of Ginkgo Biloba (EGb761): Insights into the Mechanisms of Action
   Amany R. Mahmoud et al, 2019, Cells Tissues Organs CrossRef
8. Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma
   Staci L. Haney et al, 2022, Drug Development Research CrossRef
9. Effect of different solvents on nisin ZP potential as anticancer agent against MG-63 osteosarcoma cells
   Muhammad Fairuz Azmi et al, 2022, APJMBB CrossRef
10. null
    José M. García-Castellano et al, 2022 CrossRef
11. Biomechanical Aspects in Bone Tumor Engineering
    Ksenia Menshikh et al, 2023, Tissue Engineering Part B: Reviews CrossRef
12. Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index
    Yongjie Wang et al, 2024, Clinical & Translational Med CrossRef
13. Statins as a Combatant for Treatment of Glioblastoma
    ARATI GANESH JAYBHAYE et al, 2024, J. Drug Delivery Ther. CrossRef